Wasatch Advisors’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
FLAM
AIC
KCM
RHJA
GIPM
Wasatch Advisors's OPRX Position: Q3 2023 in Review
Wasatch Advisors sold out of OptimizeRx (OPRX) in Q3 2023, closing a stake of 458,641 shares — an estimated $6.55M sold.
Wasatch Advisors first reported a position in OPRX in Q3 2018 and held it in 17 quarters. The position peaked at $11.4M in Q2 2021. 94 funds tracked by Wall St. Rank hold OPRX as of Q3 2023.
- Wasatch Advisors reported no remaining OptimizeRx position as of Q3 2023 after selling out during the quarter.
- Wasatch Advisors sold 458,641 OptimizeRx shares in Q3 2023, an estimated $6.55M.
- Wasatch Advisors first reported a position in OptimizeRx in Q3 2018 and held it in 17 quarters.
- Wasatch Advisors's OptimizeRx position peaked at $11.4M in Q2 2021.
- 94 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2023.
Based on Wasatch Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.